Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID | Title | Descriptor ▲ |
|---|---|---|---|
| 7PS2 | 7PS2 | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-29 and Beta-53 Fabs | |
| 7PS2 | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-29 and Beta-53 Fabs | |
| 7PS4 | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-38 | |
| 7PS4 | 7PS4 | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-38 | |
| 7PS5 | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-47 Fab | |
| 7PS5 | 7PS5 | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-47 Fab | |
| 7PS6 | 7PS6 | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-44 and Beta-54 Fabs | |
| 7PS6 | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-44 and Beta-54 Fabs | |
| 7PTR | P25062 | Structure of hexameric S-layer protein from Haloferax volcanii archaea | |
| 7PTU | P25062 | Structure of pentameric S-layer protein from Halofaerax volcanii | |
| 7Q6E | P0DTC2 | Beta049 fab in complex with SARS-CoV2 beta-Spike glycoprotein, The Beta mAb response underscores the antigenic distance to other SARS-CoV-2 variants | |
| 7Q6E | 7Q6E | Beta049 fab in complex with SARS-CoV2 beta-Spike glycoprotein, The Beta mAb response underscores the antigenic distance to other SARS-CoV-2 variants | |
| 7Q9F | P0DTC2 | Beta-50 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9F | 7Q9F | Beta-50 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9G | P0DTC2 | COVOX-222 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9G | 7Q9G | COVOX-222 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9I | P0DTC2 | Beta-43 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9I | 7Q9I | Beta-43 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9J | P0DTC2 | Beta-26 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9J | 7Q9J | Beta-26 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9K | P0DTC2 | Beta-32 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9K | 7Q9K | Beta-32 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9M | P0DTC2 | Beta-53 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9M | 7Q9M | Beta-53 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9P | P0DTC2 | Beta-06 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9P | 7Q9P | Beta-06 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7RPV | Q9BYF1 | Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD | |
| 7RPV | P0DTC2 | Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD | |
| 7SHT | P12319 | Structure of a partially disrupted IgE high affinity receptor complex bound to an omalizumab variant | |
| 7SHT | P01854 | Structure of a partially disrupted IgE high affinity receptor complex bound to an omalizumab variant | |
| 7SHT | 7SHT | Structure of a partially disrupted IgE high affinity receptor complex bound to an omalizumab variant | |
| 7SHU | P01854 | IgE-Fc in complex with omalizumab variant C02 | |
| 7SHU | 7SHU | IgE-Fc in complex with omalizumab variant C02 | |
| 7SHY | P01854 | IgE-Fc in complex with omalizumab scFv | |
| 7SHY | 7SHY | IgE-Fc in complex with omalizumab scFv | |
| 7SI0 | P01854 | IgE-Fc in complex with 813 | |
| 7SI0 | 7SI0 | IgE-Fc in complex with 813 | |
| 7SN0 | Q9BYF1 | Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunocompromised patient (d146*) in complex with human receptor ACE2 | |
| 7SN0 | A0A7U0MIF7 | Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunocompromised patient (d146*) in complex with human receptor ACE2 | |
| 7SN2 | P0DTC2 | Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab | |
| 7SN2 | 7SN2 | Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab | |
| 7SN3 | P0DTC2 | Structure of human SARS-CoV-2 spike glycoprotein trimer bound by neutralizing antibody C1C-A3 Fab (variable region) | |
| 7SN3 | 7SN3 | Structure of human SARS-CoV-2 spike glycoprotein trimer bound by neutralizing antibody C1C-A3 Fab (variable region) | |
| 7VLX | S5LAD9 | Cryo-EM structures of Listeria monocytogenes man-PTS | |
| 7VLX | A0A1E8EBU8 | Cryo-EM structures of Listeria monocytogenes man-PTS | |
| 7VLY | P29430 | Cryo-EM structure of Listeria monocytogenes man-PTS complexed with pediocin PA-1 | |
| 7VLY | S5LAD9 | Cryo-EM structure of Listeria monocytogenes man-PTS complexed with pediocin PA-1 | |
| 7VLY | A0A1E8EBU8 | Cryo-EM structure of Listeria monocytogenes man-PTS complexed with pediocin PA-1 | |
| 6YAX | P31995 | Crystal structure of CD32b (Fc Gamma Receptor IIb) in complex with Human IgG1 Fab fragment (5C05) | |
| 6YAX | 6YAX | Crystal structure of CD32b (Fc Gamma Receptor IIb) in complex with Human IgG1 Fab fragment (5C05) |
